Panagora Asset Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Hold
11,949
﹤0.01% 1129
2026
Q1
$161K Hold
11,949
﹤0.01% 1114
2025
Q4
$149K Hold
11,949
﹤0.01% 1147
2025
Q3
$118K Hold
11,949
﹤0.01% 1121
2025
Q2
$107K Sell
11,949
-2,194
-16% -$18.6K ﹤0.01% 1088
2025
Q1
$123K Sell
14,143
-83,429
-86% -$876K ﹤0.01% 1070
2024
Q4
$1.21M Buy
97,572
+53,139
+120% +$653K 0.01% 620
2024
Q3
$516K Sell
44,433
-8
-0% -$92 ﹤0.01% 922
2024
Q2
$472K Sell
44,441
-54,100
-55% -$598K ﹤0.01% 929
2024
Q1
$1.18M Hold
98,541
0.01% 740
2023
Q4
$1.07M Hold
98,541
0.01% 783
2023
Q3
$972K Buy
98,541
+12
+0% +$125 0.01% 787
2023
Q2
$983K Sell
98,529
-228,942
-70% -$2.19M 0.01% 789
2023
Q1
$3.15M Buy
327,471
+173,784
+113% +$1.93M 0.02% 459
2022
Q4
$1.71M Sell
153,687
-20,003
-12% -$209K 0.01% 680
2022
Q3
$1.48M Buy
173,690
+56,580
+48% +$557K 0.01% 708
2022
Q2
$1.23M Hold
117,110
0.01% 808
2022
Q1
$1.27M Buy
117,110
+44,682
+62% +$589K 0.01% 831
2021
Q4
$980K Sell
72,428
-5,439
-7% -$72.6K 0.01% 927
2021
Q3
$1.05M Sell
77,867
-53,526
-41% -$759K 0.01% 946
2021
Q2
$1.88M Sell
131,393
-608,063
-82% -$8.8M 0.01% 728
2021
Q1
$10.3M Sell
739,456
-27,881
-4% -$454K 0.06% 300
2020
Q4
$14.4M Buy
767,337
+732,294
+2,090% +$11.9M 0.09% 213
2020
Q3
$520K Buy
35,043
+398
+1% +$6.36K ﹤0.01% 1151
2020
Q2
$557K Buy
34,645
+3,466
+11% +$56.2K ﹤0.01% 1162
2020
Q1
$465K Buy
31,179
+5,354
+21% +$103K ﹤0.01% 1149
2019
Q4
$519K Hold
25,825
﹤0.01% 1288
2019
Q3
$511K Sell
25,825
-470
-2% -$9.22K ﹤0.01% 1275
2019
Q2
$501K Buy
26,295
+4,417
+20% +$97.7K ﹤0.01% 1425
2019
Q1
$620K Sell
21,878
-17,930
-45% -$523K ﹤0.01% 1324
2018
Q4
$1.09M Buy
39,808
+14,039
+54% +$455K 0.01% 1038
2018
Q3
$943K Sell
25,769
-283,874
-92% -$10.7M ﹤0.01% 1158
2018
Q2
$11.2M Buy
309,643
+229,496
+286% +$9M 0.04% 324
2018
Q1
$3.3M Buy
80,147
+54,040
+207% +$2.3M 0.01% 685
2017
Q4
$1.1M Buy
26,107
+251
+1% +$9.6K ﹤0.01% 1096
2017
Q3
$811K Sell
25,856
-7,853
-23% -$267K ﹤0.01% 1201
2017
Q2
$1.31M Buy
33,709
+4,341
+15% +$167K 0.01% 1013
2017
Q1
$1.15M Sell
29,368
-156,573
-84% -$6.31M ﹤0.01% 1082
2016
Q4
$7.09M Buy
185,941
+5,209
+3% +$194K 0.03% 461
2016
Q3
$6.89M Buy
180,732
+156,146
+635% +$6.94M 0.03% 469
2016
Q2
$1.06M Buy
24,586
+9,898
+67% +$438K 0.01% 1108
2016
Q1
$681K Sell
14,688
-1,144
-7% -$55.2K ﹤0.01% 1245
2015
Q4
$856K Sell
15,832
-1,507
-9% -$72.5K ﹤0.01% 1117
2015
Q3
$698K Sell
17,339
-200,168
-92% -$11.2M ﹤0.01% 1190
2015
Q2
$14.8M Sell
217,507
-157,474
-42% -$11.1M 0.07% 284
2015
Q1
$22.3M Buy
374,981
+136,456
+57% +$7.78M 0.11% 203
2014
Q4
$13.4M Sell
238,525
-105,847
-31% -$5.68M 0.07% 272
2014
Q3
$15.7M Sell
344,372
-1,023,373
-75% -$49.7M 0.08% 255
2014
Q2
$70.5M Sell
1,367,745
-93,364
-6% -$4.59M 0.34% 75
2014
Q1
$71.3M Buy
1,461,109
+100,859
+7% +$4.9M 0.34% 76
2013
Q4
$59M Buy
1,360,250
+446,242
+49% +$18.3M 0.27% 87
2013
Q3
$34.9M Buy
914,008
+211,948
+30% +$7.46M 0.17% 122
2013
Q2
$21.8M Buy
+702,060
New +$21M 0.11% 175

Other funds holding VTRS

Panagora Asset Management's VTRS Position: Q2 2026 in Review

Panagora Asset Management held its Viatris (VTRS) position steady in Q2 2026 at 11,949 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Panagora Asset Management first reported a position in VTRS in Q2 2013 and has held it in 53 quarters since. The position peaked at $71.3M in Q1 2014. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Panagora Asset Management held 11,949 shares of Viatris worth $190K as of Q2 2026.
  • Panagora Asset Management left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1129 holding.
  • Panagora Asset Management first reported a position in Viatris in Q2 2013 and has held it in 53 quarters since.
  • Panagora Asset Management's Viatris position peaked at $71.3M in Q1 2014.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.